Antiretroviral therapy is associated with a decrease in unintegrated HIV-1 DNA in pediatric patients

R M Donovan1, C E Bush, S M Smereck

  • 1Department of Infectious Diseases, Henry Ford Hospital, Detroit, Michigan 48202.

Insights

Unintegrated HIV-1 DNA (uDNA) reliably decreases with antiretroviral therapy in children. This study suggests uDNA is a promising marker for monitoring treatment efficacy in pediatric HIV patients.

Area of Science:

  • Virology
  • Pediatric Infectious Diseases
  • Immunology

Background:

  • Effective monitoring of antiretroviral therapy (ART) in children with human immunodeficiency virus (HIV) is crucial for optimizing treatment outcomes.
  • Current biomarkers for assessing ART efficacy in pediatric populations are limited, necessitating the evaluation of novel markers.

Purpose of the Study:

  • To investigate the impact of ART on various markers of HIV-1, including unintegrated DNA (uDNA), integrated DNA (iDNA), immune complex dissociated (ICD) p24 antigenemia, and plasma viral titer.
  • To identify reliable indicators for monitoring ART efficacy in children living with HIV-1.

Main Methods:

  • Longitudinal study of seven children initiating ART, with sample collection at baseline, 3 months, and 10 months.
  • Quantification of HIV-1 uDNA, iDNA, ICD p24 antigen, and plasma viral load at each time point.
  • Statistical analysis to assess changes in measured parameters following ART initiation.

Main Results:

  • A significant decrease in the percentage of HIV-1 uDNA was observed, from an average of 43% at baseline to 18% at 3 months (p=0.01) and 1% at 10 months.
  • HIV-1 iDNA levels remained relatively constant throughout the study period.
  • ICD p24 antigen levels showed variable responses, decreasing in three patients and remaining unchanged in four.
  • Plasma viral cultures were positive in only one child pre-therapy.

Conclusions:

  • Measurement of HIV-1 uDNA is a reliable indicator that decreases following nucleoside-based antiretroviral therapy in children.
  • Unintegrated HIV-1 DNA shows potential as a valuable biomarker for monitoring ART efficacy in pediatric HIV management.

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...